3-Hydroxycapric acid
CAS No. 14292-26-3
3-Hydroxycapric acid ( —— )
Catalog No. M20794 CAS No. 14292-26-3
3-hydroxydecanoic acid is a medium-chain fatty acid.?It has a role as an antimitotic and an Escherichia coli metabolite.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 36 | Get Quote |
|
5MG | 58 | Get Quote |
|
10MG | 87 | Get Quote |
|
25MG | 170 | Get Quote |
|
50MG | 282 | Get Quote |
|
100MG | 421 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name3-Hydroxycapric acid
-
NoteResearch use only not for human use.
-
Brief Description3-hydroxydecanoic acid is a medium-chain fatty acid.?It has a role as an antimitotic and an Escherichia coli metabolite.
-
Description3-hydroxydecanoic acid is a medium-chain fatty acid.?It has a role as an antimitotic and an Escherichia coli metabolite.
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14292-26-3
-
Formula Weight188.26
-
Molecular FormulaC10H20O3?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCC(O)CC(=O)O
-
Chemical Name(S)-3-hydroxydecanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Iwanami Y . Myrmicacin a new inhibitor for mitotic progression after metaphase[J]. Protoplasma 1978 95(3):267-271.
molnova catalog
related products
-
2-Methoxyestrone
2-Methoxyestrone is a methoxylated catechol estrogen and the principal metabolite of 2-hydroxyestrone, a nonuterotropic metabolite of estradiol.
-
5α-Cholestane
5α-Cholestane belongs to the class of organic compounds known as cholestane steroids.
-
1-Methylhistamine di...
1-Methylhistamine dihydrochloride is a major metabolite of histamine by histamine N-methyltransferase in the pathway of histidine metabolism.?It has been used as a biomarker of histaminergic system activity in the brains of Alzheimer's disease patients as well as those with hypersomnia and other neurological conditions.